Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Real-Time Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01951 JXR
RTNominal up11.860 +0.140 (+1.195%)
Others

15/10/2019 09:35

{I-bank focus}CS raises Jinxin Fertility (01951) to HK$15.12

[ET Net News Agency, 15 October 2019] Credit Suisse raised its target price for Jinxin
Fertility (01951) to HK$15.12 from HK$12.25 and maintained its "outperform" rating.
The research house said the target price hike was based on management's reiteration on
M&A expansion, increased margin from optimised revenue mix in the Xinan hospital, and the
positive impact from restructuring in the Zhongshan hospital.
Jinxin reiterated its ability to maintain high success rates at each of its hospitals,
achieving 20% top-line growth across its hospital network and continuing to seek M&A
opportunities where it can add value to existing businesses and that it will focus on
targets that have strong regional market potential.
Credit Suisse lifted its 2019-21 EPS forecasts by 3-7%. (KL)

Remark: Real time quote last updated: 09/12/2019 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2019 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.